New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 3, 2012
12:47 EDTIPSEYIpsen, Galderma increase collaboration for Dysport in new territories
Ipsen and Galderma announced that their collaboration for the promotion and distribution of Dysport, Ipsenís botulinum toxin type A in aesthetic indications, has been extended. Both companies renewed their collaboration in Brazil and Argentina and extended their partnership to Australia where Galderma has the exclusive promotion and distribution rights for Ipsenís Dysport in glabellar lines indication. Both companies also entered into a co-promotion agreement in South Korea where Galderma and Ipsen will co-promote Dysport and Restylane.
News For IPSEY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 16, 2014
16:46 EDTIPSEYIpsen receives approval for Somatuline Depot Injection from FDA
Ipsen Biopharmaceuticals announced that Somatuline Depot Injection 120 mg was approved by the FDA for the treatment of gastroenteropancreatic neuroendocrine tumors, or GEP-NETs, in adult patients with unresectable, well or moderately differentiated, locally advanced or metastatic disease to improve progression-free survival.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use